Eyewire Today


Archives: Acquisitions/Mergers

Show articles per page

Thursday, August 28, 2014

Valeant, Ackman get October 6 Trial Over Allergan Special Meeting

From Reuters

Valeant Pharmaceuticals International and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $50 billi... Read full article

Wednesday, August 27, 2014

Alcon to Acquire WaveTec Vision, Developer of ORA Intraoperative Guidance S...

From Alcon

Alcon announced that the company has entered into an agreement to acquire privately held WaveTec Vision, the developer of the ORA System, the first commercialized intraoperative guidance system, according to a company ne... Read full article

Wednesday, August 27, 2014

Allergan to Hold Special Shareholder Meeting in December

From FirstWord

Allergan revealed Tuesday that it will hold a special shareholder meeting, during which William Ackman's Pershing Square Capital Management will seek to replace six members of the company's board, on December 18. The ann... Read full article

Tuesday, August 26, 2014

Allergan Receives Written Requests from Pershing Square Regarding Special M...

From Allergan

Allergan confirmed that Pershing Square Capital Management has delivered written requests from Allergan stockholders in connection with Pershing Square's request to call a special meeting of stockholders, according to a ... Read full article

Monday, August 25, 2014

Valeant Says Allergan Investors Demand Meeting on Deal

From Bloomberg

Valeant and Pershing Square Capital Management said 31% of Allergans shareholders support their effort to call a special meeting as part of Valeants $54 billion takeover bid for the maker of the Botox anti-wrinkle cream.... Read full article

Monday, August 25, 2014

Roche Holding Agrees to Buy InterMune for $8.3 Billion

From Bloomberg

Roche Holding AG agreed to buy InterMune Inc. for about $8.3 billion in cash, gaining access to what may be the first drug in the U.S. for a lung disease that can be fatal within five years of diagnosis. Roche will pay $... Read full article

Friday, August 22, 2014

Allergan Talks to Buy Salix in Defense Move Said to Be Dormant

From Bloomberg

Allergan isnt currently in active talks to acquire Salix Pharmaceuticals Ltd., people with knowledge of the matter said, though the drugmakers have discussed a deal. Allergan, seeking to stave off a hostile bid from Vale... Read full article

Thursday, August 21, 2014

Could Buying Salix Get Valeant off of Allergan's Scent?

From Fierce Biotech

Allergan, working to fend off a hostile approach from Valeant Pharmaceuticals, is reportedly taking a look at the smaller Salix Pharmaceuticals, weighing a multibillion-dollar deal that could render it unattainable--or a... Read full article

Wednesday, August 20, 2014

WSJ: Allergan Contacted Salix Pharmaceuticals About Possible Takeover

From Eyewiretoday.com

According to a report in the Wall Street Journal, Allergan has approached Salix Pharmaceuticals about a potential acquisition that could thwart the $53 billion hostile bid for Allergan by Valeant, according to people fam... Read full article

Monday, August 18, 2014

Valeant Extends Tender Offer for Allergan Until Year End

From Bloomberg

Valeant said it extended its offer to purchase Allergan until the end of the year, after an initial deadline for its tender offer was scheduled to expire today. Valeant has joined with the hedge fund Pershing Square Capi... Read full article

Friday, August 15, 2014

Pershing Says It Welcomes SEC Review of Allergan Bid

From Bloomberg

Pershing Square Capital Management LP, which teamed with Valeant to bid for Allergan, said it welcomes a U.S. Securities and Exchange Commission review of its takeover tactics and defended them. There is nothing illegal,... Read full article

Thursday, August 14, 2014

SEC Reportedly Investigating Valeant, Pershing Square's Hostile Takeover Bi...

From Eyewiretoday.com

According to a report in the Wall Street Journal, the US Securities and Exchange Commission has launched a civil probe into Valeant Pharmaceuticals and Pershing Square Capital Management's joint takeover attempt for Alle... Read full article

Thursday, August 07, 2014

Allergan Comments on ISS and Glass Lewis Recommendations

From Allergan

Allergan issued the following statement regarding reports by Institutional Shareholder Services (ISS) and Glass Lewis on Pershing Square Capital Management's solicitation to call a special meeting of Allergan's stockhold... Read full article

Thursday, August 07, 2014

Allergan Shareholders Should Back Meeting, ISS Says

From Bloomberg

Allergan Inc. shareholders should support a special meeting, a second investor advisory firm said in a boost to Valeant Pharmaceuticals International Inc.s efforts to take over the company. The recommendations are making... Read full article

Tuesday, August 05, 2014

Roche to Acquire Santaris Pharma to Expand Discovery and Development of RNA...

From Roche

Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark, according to a company news release. Santaris Pharma has pioneered its proprietary... Read full article

Monday, July 28, 2014

Alphaeon Acquires PRN Specialty Nutriceutical Company

From Alphaeon Corp.

Alphaeon, a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired Physician Recommended Nutriceuticals (PRN) of Plymouth Meeting, Pennsylvania, a developer of specialty omega-3s ... Read full article

Friday, July 18, 2014

AbbVie Is Biggest to Quit U.S. Address in $55 Billion Shire Deal

From Bloomberg

AbbVie Inc. agreed to buy Shire Plc for 32 billion pounds ($54.8 billion), becoming the largest U.S. company to ever take a foreign address to lower its taxes. Shire holders will receive cash and stock valued at 52.48 po... Read full article

Thursday, July 17, 2014

NanoVision Group and OVI Lens Enter Into Advanced Technology Collaboration ...

From NanoVision Group

NanoVision Group and OVI Lens, Italy, have reached an agreement for the manufacturing and distributing of ophthalmic products, and for a collaboration on new technology development, according to a a company news release.... Read full article

Thursday, July 17, 2014

Ackman Urges Allergan to Enter Takeover Negotiations with Valeant

From FirstWord

In a letter to Allergan's board released Wednesday, Pershing Square Capital Management CEO William Ackman criticized directors for their "scorched-earth response" to Valeant Pharmaceuticals' $53.8-billion takeover propos... Read full article

Wednesday, July 09, 2014

Allergan Planning Cost Cuts Amid Valeant Defense

From Bloomberg

Allergan Inc., the Botox maker being pursued by Valeant Pharmaceuticals International Inc. and Bill Ackman's hedge fund, will shelve unpromising pipeline drugs and overhaul management incentives, two people with knowledg... Read full article


Featured Jobs
  • General Ophthalmologist

    , FL (Statewide)

    Established over 60 years ago, one of Floridas busiest and most respected practices is seeking an experience general ophthalmologist. Ideal candidate will have an interest and experience in glaucoma or light plastics as ...